Results 71 to 80 of about 12,222 (228)
Shear‐induced blood damage—including hemolysis, platelet and neutrophil injury, and von Willebrand factor (vWF) degradation—was evaluated for the BrioVAD and HM3 using an in vitro circulatory loop under clinically relevant conditions. Across 15 biomarkers (n > 6 per group), no significant differences were observed between the two devices.
Wenji Sun +9 more
wiley +1 more source
Frank-starling control of a left ventricular assist device
A physiological control system was developed for a rotary left ventricular assist device (LVAD) in which the target pump flow rate (LVADQ) was set as a function of left atrial pressure (LAP), mimicking the Frank-Starling mechanism.
Stevens, Michael Charles +19 more
core +1 more source
This mixed methods study aimed to: (i) identify treatment expectations held by individuals with a ventricular assist device (VAD), (ii) assess the extent to which these expectations have been met, and (iii) examine how treatment expectations relate to VAD‐specific health‐related quality of life (HRQoL) ABSTRACT Objectives Treatment expectations ...
Simon Felix Zerth +10 more
wiley +1 more source
How Formal and Informal Nurse Leaders Enact Shared Implementation Leadership in a Hospital Setting
ABSTRACT Aim To describe how implementation leadership manifests among formal and informal point of care nurse leaders during a successful evidence‐based practice implementation. Design A collective case study. Methods A conceptual framework on shared implementation leadership guided the study. Two units known for strong implementation were selected as
Sonia Angela Castiglione +4 more
wiley +1 more source
Exclusion criteria; LVAD, left ventricular assist device.
Exclusion criteria; LVAD, left ventricular assist device.
Yvonne Roca (14539364) +5 more
core +1 more source
Despite the increasing prevalence of advanced heart failure, transplantation rates have remained stable in Canada due to limited organ availability. Consequently, the number of implanted left ventricular assist devices (LVAD) and average time on device ...
Tremblay, Philippe
core
Anticoagulation Monitoring in Left Ventricular Assist Device (LVAD) Patients
The use of left ventricular assist devices (LVAD) provides a treatment strategy for advanced heart failure patients to prolong life and serve as a mediator (bridge to transplant) until an organ becomes available in patients considered suitable candidates for heart transplantation.
Sieg, Adam +4 more
openaire +2 more sources
ABSTRACT Background Unsuccessful defibrillation therapy in patients with implantable cardiac defibrillators (ICDs) and ventricular tachytherapies may occur due to patient and/or device‐related factors; appropriate management strategies after failed defibrillation therapy have been incompletely described.
Nathaniel Christian‐Miller +9 more
wiley +1 more source
Objective Investigate the safety and efficacy of preoperative levosimendan in patients undergoing left ventricular assist device (LVAD) implantation.
Amitai Segev +9 more
doaj +1 more source
Centrifugal pump performance characteristics are vital in determining the ability of a prototype left ventricular assist device (LVAD) to meet the physiological circulation requirements of the cardiovascular system.
Hayne, Mark S. +3 more
core +1 more source

